Lau, Gee
Education
BS, University of Wisconsin-Madison (Bacteriology. Advisor: Prof. Kenneth Todar)
MS, University of Wisconsin-Madison (Bacteriology; MS thesis in fungal pathogenesis. Advisor: Prof. Albert Ellingboe)
PhD, Purdue University, West Lafayette, IN (Molecular Biology; PhD thesis in fungal pathogenesis. Advisor: Prof. John Hamer)
Postdoctoral Fellow, Imperial College School of Medicine, London (Bacterial pathogenesis. Advisor: Prof. David Holden)
Postdoctoral Fellow, Massachusetts General Hospital, Harvard Medical School, Boston (Bacterial pathogenesis. Advisor: Prof. Laurence Rahme)
Research Interests
Modulation of airway immune response and induction of mucus hypersecretion by respiratory pathogens.
Regulation of genetic transfer and virulence by Streptococcus pneumoniae competence regulon.
Efficacy and safety of non-antibiotic alternatives against ESKAPEE pathogens.
Links
http://textbookofbacteriology.net/ken_todar.html
https://micronations.wiki/wiki/Main_Page
https://www.merckvetmanual.com
https://www.ncbi.nlm.nih.gov/pubmed/?term=lau+gw
https://scholar.google.com/citations?view_op=list_works&hl=en&user=DUOlwBQAAAAJ
Biography
BiographyDr. Lau was a Research Assistant Professor in the Division of Pulmonary, Critical Care and Sleep Medicine, University of Cincinnati College of Medicine, where he researched the immune modulation and induction of mucus hypersecretion in bronchiectatic airways by Pseudomonas aeruginosa and the antimicrobial properties of pulmonary surfactant proteins. He joined the UIUC in 2006 and is currently a Professor of Microbiology and Immunology in the Department of Pathobiology, College of Veterinary Medicine.
Courses Taught
Veterinary Bacteriology and Mycology (Path 603).
Pathobiologic Basis of Disease II (VM607).
Graduate student journal club and data club.
Independent studies and thesis research for high school, undergraduate, DVM and graduate students.
Research training for postdoctoral fellows, clinical residents and visiting scholars.
Selected Publications
Please refer to our publications on PubMed and Google Scholar.
https://pubmed.ncbi.nlm.nih.gov/?term=lau+gw&sort=date
https://scholar.google.com/citations?view_op=list_works&hl=en&user=DUOlwBQAAAAJ
Grants
Over the past > 20 years, the Lau lab has been continuously funded by various national funding agencies and/or private foundations, including the National Institute of Health, the Department of Defense, Cystic Fibrosis Foundation, the American Lung Assocciation, and industries.
Honors and Awards
Travel Award. American Thoracic Society 100 International Conference. Assembly on Microbiology, Tuberculosis and Pulmonary Infections (MTPI) (2004)
American Lung Association Desouza Research Award (2011)
University of Illinois at Urbana-Champaign Arnold O Beckman Research Award (2011)
UIUC College of Veterinary Medicine Dr. Gordon and Mrs. Helen Kruger Research Excellence Award (2012)
UIUC College of Veterinary Medicine Zoetis Research Excellence Award (2016)
UIUC Teachers ranked as excellent by their students (2013-2023, consecutive years)
UIUC College of Veterinary Medicine Dr. Erwin Small Teaching Excellence Award (2021)
Professional Affiliations
American Society for Microbiology
Society for Mucosal Immunology
Selected Service Activities
Manuscript Review: 2005-present:
Science Advances, PNAS, PLoS Pathog, PLoS Genet, Advanced Science, JCI Insights, Clin Transl Med, EBioMedicine, Mucosal Immunol, J Immunology, Front Immunol, J Leukoc Biol, Eur Respir J, Inflamm Res, Respir Res, Int J COPD, mBio, Trends Microbiol, Cell Microbiol, Mol Microbiol, Infect Immun, J Bacteriol, Antimicrob Agents Chemother, ACS Infect Dis, ACS Chem Biol, Free Radic Biol Med, Int J Mol Sci, etc.
Editorial duty(2012-present)
Editorial Board
2023 - present Lead Special Topic Editor, Frontiers in Immunology (Modulation of pulmonary immunity and function by bacterial and host metabolites) (Co-editors Laurence Rahme, Roger Levesque)
2020 – present Associate Editor, Frontiers in Immunology - Microbial Immunology Section
2020 - 2023 Associate Editor, Virulence (Respiratory Pathogens) (2019-2020, Editor)
2019 - 2020 Special Topic Editor, Frontiers in Immunology (Outsmarting the Host: How Bacterial Pathogens Modulate Immune Responses in The Lung. Coeditors: Charles DelaCruz, Michael Borchers)
2017- present Editorial Board Member, Infection and Immunity
2016 - 2024 Associate Editor, The Journal of Microbiology
2015 - 2017 Consulting Editor, International Journal of Chronic Obstructive Pulmonary Disease
Grant Review (since 2006, out of 62 national/international agencies and foundations)
2024 NIH/NIDDK Cystic Fibrosis Centers grant applications (11/2024)
2024 NIH Infectious Diseases and Immunology Fellowship panel ZRG1-IIDB-F07A-(20)
2024 NIH Special Emphasis Panel (SEP) ZRG1 IIDA-M (02), Topics in Bacterial Virulence
2023 NIH Infectious Diseases and Immunology Fellowship panel ZRG1-IIDB-F07B-(20)
2023 NIH Lung Cellular and Molecular Immunology Study Section (LCMI)
2023 NIH Infectious Diseases and Immunology Fellowship panel ZRG1-IIDB-F07A-(20)
2023 NIH. Ad hoc, Respir. Integrative Biology & Translational Research (RIBT)
2023 Reviewer, Medical Research Council, United Kingdom (02/2023)
2022 NIH/NHLBI. Ad hoc, Lung Cellular and Molecular Immunology (LCMI)
2022 NIH/NHLBI Program Project Grant Study Section (HLBP L (13)
2021 NIH/NHLBI. Ad hoc, Respir. Integrative Biology & Translational Research (RIBT)
2021 NIH/NIAID, 2021/10 ZRG1 ID1A-B (80) S, Topics in Bacterial Pathogenesis (R21 and R03)
2021 NIH/NHLBI. Ad hoc, Respir. Integrative Biology & Translational Research (RIBT)
2021 NIH Special Emphasis Panel 2022/01 ZRG1 IDIB-N (90) S meeting (Pulmonary Immune Host Defense)
2020 NIH/NHLBI. Ad hoc, Respir. Integrative Biology & Translational Research (RIBT) Study Section
2020 Department of Defense Pre-applications in Respiratory Health 2020 PRMRP PRE-RH-1 (CDMRP)
2020 NIH/NIAID F13 Infectious Diseases & Microbiology Fellowship Panel (07/2020)
2019-Present Am. Lung Assoc., Allergic Respir. Dis. Research Award and Catalyst Research Grant panel
2019 NIH/NIAID, 2019/10 ZRG1 IDM-B (80) S meeting, Topics in Bacterial Pathogenesis (R21 and R03)
2019 NIH/NIAID F13 Infectious Diseases & Microbiology Fellowship Panel (2020/01 ZRG1 F13-Z (20) L)
2019 NIH/NIDDK Special Emphasis Panel/Scientific Review Group 2020/01 ZDK1 GRB-M (J1) P
2019 Department of Defense Pre-applications in Respiratory Health (PRMRP) (CDMRP)
2019 Swiss National Science Foundation External Grant Reviewer
2018 Reviewer, Committee on Cell & Developmental Biology, French National Research Agency
2018 NIH/NHLBI Special emphasis panel, Pulmonary Diseases (ZRG1 CVRS-N (03) M)
2018 NIH/NIAID Special emphasis panel, Bacterial pathogenesis & host interactions. ZRG1 IDM (02)
2018 Special emphasis panel, NIH/NHLBI RFA-17-015, Bold New Bioengineering Methods and Approaches for Heart, Lung, Blood and Sleep Disorders and Diseases, Lung and Blood Disorders (R21)
2017 NIH/NHLBI. Special Emphasis Panel Pulmonary Diseases 2017/10 ZRG1 CVRS-N (03) M meeting
2017 NIH/NHLBI. Special Emphasis Panel 2018/01 ZHL1 CSR-P (F1). 1 RFA HL-17-015 “Bold New Bioengineering Methods for Heart, Lung, Blood and Sleep Disorders and Diseases”
2016 Reviewer, The Netherlands Org. for Scientific Research (NWO) Innovational Research
2016 NIH/NIAID RFA-Al-16-022: Human Tissue Models for Infectious Diseases U19 Center Grant
2016 National Science Foundation, The Faculty Early Career Development (CAREER) Program application
2015 Reviewer, Committee on Cell & Developmental Biology, French National Research Agency
2015 NIH/NIAID. Topics in Bacterial Pathogenesis study section -- IDM-B (80)
2015 Reviewer, Infection and Immunity (IIB) Medical Research Council, United Kingdom
2013-2018 American Lung Association, Senior Research Fellowship Applications
2013 NIH/NIAID RFA-AI-13-019 Drug Target Development & Validation for Antimicrobial Resistant Pathogens
2012-2014 Danish Council for Independent Research, Technology & Production Sciences
Resources
Please direct your inquiries to Dr. Lau regarding potential collaboration on various preclinical rodent models of human infectious diseases and the availability of Pseudomonas aeruginosa and Streptococcus pneumoniae strains.